No Apparent Short-Term Cancer Risk From Recalled Valsartan

THURSDAY, Sept. 13, 2018 -- Users of valsartan contaminated with N-nitrosodimethylamine (NDMA) seem not to have increased cancer risk, according to a study published online Sept. 12 in The BMJ. Anton Potteg ård, Ph.D., from the University of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news

Related Links:

To go along with its tagline “No One Travels This Road Alone,” this organization does all it can to support those in the community during their battles with cancer. The 2018 Community Supporter Business of the Year, Pink Ribbon Girls serves those fighting breast and gynecological cancers by offering a variety of free servi ces, including transportation to and from treatment, access to healthy meals, house cleaning services and avenues for peer support. A majority of the organization’s clients…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
Janna Clark, 36, of Harold Wood, Essex, had dismissed her symptoms of tiredness, headaches, and blurred vision down to stress. Surgeons had to remove her eye because of the tumour inside.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Publication date: Available online 12 November 2018Source: Journal of Organometallic ChemistryAuthor(s): Fei-fei Yan, Qi Zhu, Qian-Li Li, Ru-Fen Zhang, Chun-Lin MaAbstractSix new triorganotin complexes, [(R3Sn)2(O2CC5H3NS)2]n (R = Me: 1; n-Bu: 2), [(R3Sn)2(O2CC6H4S)2]n (R = Me: 3; n-Bu: 4), [(R3Sn)2(O2CCH2S)2]n (R = Me: 5; n-Bu: 6) have been obtained by the reaction of R3SnCl (R = Me, n-Bu) with the corresponding dicarboxylate ligands (H2L1 = 6,6’-dithiodinicotinic acid, H2L2 = 2,2’-dithiodibenzoic acid, H2L3 = dithiodiglycolic acid). All the compounds were characterized by elemental...
Source: Journal of Organometallic Chemistry - Category: Chemistry Source Type: research
Colon cancer is the second-leading cause of cancer-related deaths in the U.S. but colonoscopies have been found to reduce the risk of death from the disease by 70 percent or more. CBS News chief medical correspondent Dr. Jon LaPook talks to New York University medical student, Rachel Sarnoff, about how the field of microbiomes could be the next frontier of colon cancer research.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
Authors: Dasmahapatra AK, Dasari TPS, Tchounwou PB Abstract Due to their unique physicochemical properties, graphene-based nanoparticles (GPNs) constitute one of the most promising types of nanomaterials used in biomedical research. GPNs have been used as polymeric conduits for nerve regeneration and carriers for targeted drug delivery and in the treatment of cancer via photothermal therapy. Moreover, they have been used as tracers to study the distribution of bioactive compounds used in healthcare. Due to their extensive use, GPN released into s environment would probably pose a threat to living organisms and ulti...
Source: Reviews of Environmental Contamination and Toxicology - Category: Toxicology Tags: Rev Environ Contam Toxicol Source Type: research
Conclusion: Propolis extracts may be important economically, allowing a relatively inexpensive cancer treatment associated to lower concentrations of drugs. In this review, the activity and mechanisms of action of propolis and CAPE on breast cancer cells are discussed.
Source: Current Pharmacogenomics and Personalized Medicine - Category: Genetics & Stem Cells Source Type: research
Conclusion: Hairpin/cruciform or slipped-strand DNA structures extruded by inverted and direct repeats, respectively, could be involved in the induction of translocations, deletions, isochromosomes, duplications and inversions in human cancers and genetic diseases as well as the expansion of short nucleotide repeats in hereditary neurological diseases. In addition, there is a significant association between long inverted repeats (LIRs) and the breakpoint regions of gross gene deletions in human cancers and inherited diseases. Thus, this review will focus on non-B DNA structures as candidate drug targets against structural ...
Source: Current Pharmacogenomics and Personalized Medicine - Category: Genetics & Stem Cells Source Type: research
Recently, novel drugs that inhibit the enzyme poly (ADP-ribose) polymerase (PARP) based on the concept of synthetic lethality are used for cancer treatment. Three PARP inhibitors (olaparib, rucaparib and niraparib) are approved for the treatment of recurrent ovarian cancer in the US or Europe, while another two (veliparib and talazoparib) showed promising anti-cancer activity. This review aims to summarize the current status of clinical trials on PARP inhibitors and then discusses studies aimed to identify biomarkers for predicting the efficacy of PARP inhibitors.
Source: Current Pharmacogenomics and Personalized Medicine - Category: Genetics & Stem Cells Source Type: research
Conclusion: The ethanol ADH acetaldehyde system offers a simple, safe, non-toxic approach to cancer therapy prodrug toxin technology. It may also offer a safe and non-toxic system to control the number and action of T cells used in adoptive immunotherapy.
Source: Current Pharmacogenomics and Personalized Medicine - Category: Genetics & Stem Cells Source Type: research
Conclusion: Results of this study suggest that TQ modulates oxLDL-induced expression of markers in breast cancer growth.
Source: Current Pharmacogenomics and Personalized Medicine - Category: Genetics & Stem Cells Source Type: research
More News: Cancer | Cancer & Oncology | Diovan | Pharmaceuticals | Study